GoldenBiotech
@goldenbiotech.com
Golden Biotechnology Corporation (GBC, GoldenBiotech) (TPEx: 4132), founded by Mr. Sheng Yung, Liu in 2002, is a leading global biopharmaceutical company. GoldenBiotech focuses on discovery and clinical development of innovative therapeutic new drugs (NCE), and dedicated to improving quality of life by developing products that prevent and treat diseases.
GoldenBiotech's Company Logos
GoldenBiotech's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#739B42
Sushi
115, 155, 66
87, 40, 43
26, 0, 57, 39
#F7E1B5
Givry
247, 225, 181
40, 80, 84
0, 9, 27, 3
#373A3C
Outer Space
55, 58, 60
204, 4, 23
8, 3, 0, 76
About GoldenBiotech
Golden Biotechnology Corporation (GBC), founded in 2002 by Mr. Sheng Yung Liu, is a leading global biopharmaceutical company focused on the discovery and clinical development of innovative therapeutic drugs. With a mission to improve the quality of life by preventing and treating diseases, GBC is dedicated to developing products that meet the needs of patients with high unmet medical needs.
GBC's core competency lies in its advanced drug development capabilities. The company has an established team with a proven track record in clinical development, regulatory affairs, and commercialization. Their flagship product, Antroquinonol, is an innovative compound that has shown excellent efficacy and safety profiles through numerous Phase 1 and 2 studies in difficult-to-treat indications such as oncology and infectious diseases.
With a global presence and a commitment to solving the hardest questions surrounding Antroquinonol, GBC aims to ultimately benefit patients and healthcare professionals. Their dedication to advancing drug development and improving patient outcomes makes Golden Biotechnology Corporation a trusted leader in the field.
Company type
Public Company
Year founded
2002
Company size
51-200 employees
